ON DEMAND WEBINAR:
"Unmatched Viral Particle Analysis - Vaccine and Gene Therapy Development
At your convenience
The number of gene therapy applications based on viral vectors are growing and small-scale manufacturing processes are increasingly requiring scale-up to commercial processes.
Numerous challenges must be overcome in scaling-up to full commercial production. Undesired outcomes can be avoided by careful monitoring during development of the process.
In this webinar we will show how MiniTEM™ can produce powerful data where traditional assays have limitations.
key Learning Objectives
How MiniTEM automatically can:
- Screen the viral particle morphology status throughout the process
- Determine sample purity
- Detect aggregates
- Compare the portion of intact versus broken viral particles
- Indicate virus titer
Speakers: Josefina Nilsson, Head of EM services & Martin Ryner, Strategic Development Manager, both from at Vironova.